Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06154070 · ClinicalTrials.gov registry record

An Open Label, Study of DaxibotulinumtoxinA for Migraine Prevention

A clinical trial of Migraine Disorders, sponsored by Ki Health Partners..

Active
Registry status
10
Enrollment target
2
Study locations

NCT06154070 is a study of Migraine Disorders that is active but no longer recruiting, run by Ki Health Partners.. The registered enrollment target is 10 participants, below the 315-participant average among 21 other Migraine Disorders trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06154070, a study of Migraine Disorders, is active but no longer recruiting, sponsored by Ki Health Partners..

ACTIVE NOT RECRUITING
Registry status
10 participants
Enrollment target
2
Study locations

Study Summary

This is a prospective, multi-center, unblinded study in patients with migraine (≥ 8 MMDs(monthly migraine days)/month) requiring preventive treatment. Enrolled patients will receive DAXXIFY (DAX/Doxibutlinumtoxin A)administered subcutaneously per the EEG paradigm (injection pattern). The safety and efficacy outcome measures will be assessed at selected dosing segments during the 24-week treatment phase as well as the Post Treatment (4 weeks). There are 2 sites in the U.S. participating, where a total of 20 patients will be enrolled.

Conditions Studied

Migraine Disorders

Interventions

  • DRUG DaxibotulinumtoxinA

Study Locations (2)

California

  • The Los Angeles Headache Center - Los Angeles

Connecticut

  • New England Institute For Clinical Research - Stamford

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2023-10-24
Est. Completion 2024-10

Sponsor

Ki Health Partners.

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06154070

The ClinicalTrials.gov registry entry for NCT06154070 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 315-participant average among 21 other Migraine Disorders trials with a reported enrollment target (97% lower). The listed sponsor is Ki Health Partners., which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Migraine Disorders appearing as the primary indexed condition, and to 1 intervention - of which DaxibotulinumtoxinA is the first listed.

NCT06154070 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Connecticut.

Frequently Asked Questions

What is clinical trial NCT06154070 about?

NCT06154070 is a clinical study titled "An Open Label, Study of DaxibotulinumtoxinA for Migraine Prevention". This is a prospective, multi-center, unblinded study in patients with migraine (≥ 8 MMDs(monthly migraine days)/month) requiring preventive treatment. Enrolled patients will receive DAXXIFY (DAX/Doxibutlinumtoxin A)administered subcutaneously per the EEG paradigm (injection pattern). The safety an...

What is the current status of trial NCT06154070?

This trial is currently active not recruiting. The enrollment target is 10 participants. The study started on 2023-10-24. Estimated completion is 2024-10.

What conditions does trial NCT06154070 study?

This clinical trial studies the following conditions: Migraine Disorders.

What interventions are being tested in trial NCT06154070?

The interventions under investigation include: DaxibotulinumtoxinA (DRUG).

Who is sponsoring clinical trial NCT06154070?

This trial is sponsored by Ki Health Partners., which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06154070 being conducted?

This trial has 2 study locations across California, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Migraine Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Migraine Disorders

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.